293
Views
43
CrossRef citations to date
0
Altmetric
Review

Iliac vein compression: epidemiology, diagnosis and treatment

, &
Pages 115-122 | Published online: 09 May 2019

References

  • Cavalcante LP, Dos Santos Souza JE, Pereira RM, et al. Iliac vein compression syndrome: literature review. J Vasc Bras. 2015;14:78–83. doi:10.1590/1677-5449.20140027
  • May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8:419–427. doi:10.1177/00033197570080050513478912
  • Kibbe MR, Ujiki M, Goodwin AL, Eskandari M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004;39:937–943. doi:10.1016/j.jvs.2003.12.03215111841
  • Taheri SA, Williams J, Powell S, et al. Iliocaval compression syndrome. Am J Surg. 1987;154:169–172.3631389
  • Knuttinen MG, Naidu S, Oklu R, et al. May-Thurner: diagnosis and endovascular management. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S159–S164. doi:10.21037/cdt.2017.10.1429399519
  • Kahn SR, Solymoss S, Lamping DL, Abenhaim L. Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. J Gen Intern Med. 2000;15:425–429. doi:10.1046/j.1525-1497.2000.06419.x10886478
  • Van Korlaar I, Vossen C, Rosendaal F, Cameron L, Bovill E, Kaptein A. Quality of life in venous disease. Thromb Haemost. 2003;90:27–35. doi:10.1055/s-0037-161359512876622
  • Lubberts B, Paulino Pereira NR, Kabrhel C, Kuter DJ, DiGiovanni CW. What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis. Thromb Haemost. 2016;116:417–431. doi:10.1160/TH16-02-015227362694
  • Kahn SR, Ducruet T, Lamping DL, et al. Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med. 2005;165:1173–1178. doi:10.1001/archinte.165.10.117315911732
  • Catarinella FH, Nieman MA, de Wolf IM, et al. Quality-of-life in interventionally treated patients with post-thrombotic syndrome. Phlebology. 2015;30(Suppl. 1):89–94. doi:10.1177/026835551556943125729074
  • Labropoulos N, Borge M, Pierce K, Pappas PJ. Criteria for defining significant central vein stenosis with duplex ultrasound. J Vasc Surg. 2007;46(1):101–107. doi:10.1016/j.jvs.2007.02.06217540535
  • Brinegar KN, Sheth RA, Khademhosseini A, Bautista J, Oklu R. Iliac vein compression syndrome: clinical, imaging and pathologic findings. World J Radiol. 2015;7:375–381. doi:10.4329/wjr.v7.i11.37526644823
  • Zucker EJ, Gnguli S, Ghoshhajra BB, Gupta R, Prabhakar AM. Imaging of venous compression syndromes. Therapy. 2016;6:519–532. doi:10.21037/cdt
  • White JM, Comerota AJ. Venous compression syndromes. Vasc Endovascular Surg. 2017;51:155–168. doi:10.1177/153857441769720828330436
  • Birn J, Vedantham S. May–thurner syndrome and other obstructive iliac vein lesions: meaning, myth, and mystery. Vasc Med. 2014;20:74–83. doi:10.1177/1358863X1456042925502563
  • Shammas NW, Shammas GA, Jones-Miller S, et al. Predicting iliac vein compression with computed tomography angiography and venography: correlation with intravascular ultrasound. J Invasive Cardiol. 2018;30:452–455.30504513
  • Shammas NW, Rachwan RJ, Daher G, Bou Dargham B. Double inferior vena cava and its implications during endovascular and surgical interventions: a word of caution. J Invasive Cardiol. 2017;29:51–53.28145872
  • Park JY, Ahn JH, Jeon YS, Cho SG, Kim JY, Hong KC. Iliac vein stenting as a durable option for residual stenosis after catheter- directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to may-thurner syndrome. Phlebology. 2014;29:461–470. doi:10.1177/026835551349172423761876
  • Raju S, Ward M Jr, Kirk O. A modification of iliac vein stent technique. Ann Vasc Surg. 2014;28:1485–1492. doi:10.1016/j.avsg.2014.02.02624632315
  • Dake M. Available from: https://venousnews.com/vernacular-12-month-data-successful-venovo-obstructive-lesions/. Accessed 123, 2019.
  • Neglén P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg. 2007;46:979–990. doi:10.1016/j.jvs.2007.06.04617980284
  • Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38:S495–501. doi:10.1016/j.amepre.2009.12.01720331949
  • Kwak HS, Han YM, Lee YS, Jin G-Y, Chung G-H. Stents in common iliac vein obstruction with acute ipsilateral deep venous thrombosis: early and late results. J Vasc Interv Radiol. 2005;16:815–822. doi:10.1097/01.RVI.0000157690.91690.3815947045
  • Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the post thrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 2008;149:698–707.19017588
  • Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7.8644983
  • Shi Y, Shi W, Liang Chen L, et al. A systematic review of ultrasound-accelerated catheter-directed thrombolysis in the treatment of deep vein thrombosis. J Thromb Thrombolysis. 2018;45:440–451. doi:10.1007/s11239-017-1574-129417407
  • Rao AS, Konig G, Leers SA, et al. Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: an alternative in patients with contraindications to thrombolysis. J Vasc Surg. 2009;50:1092–1098. doi:10.1016/j.jvs.2009.06.05019782528
  • Enden T, Haig Y, Klow NE, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): A randomised controlled trial. Lancet. 2012;379(9810):31–38. doi:10.1016/S0140-6736(11)61753-422172244
  • Vedantham S, Goldhaber SZ, Kahn SR, et al. Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. Am Heart J. 2013;165:523–30 e3. doi:10.1016/j.ahj.2013.01.02423537968
  • Vedantham S, Goldhaber SZ, Julian J, et al. Pharmacomechanical catheter-directed thrombolysis for Deep-Vein thrombosis. The ATTRACT Trial investigators. New Engl J Med. 2017;377:2240–2252. doi:10.1056/NEJMoa161506629211671
  • Wang W, Sun R, Chen Y, Liu C. Meta-analysis and systematic review of percutaneous mechanical thrombectomy for lower extremity deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2018;6(6):788–800. doi:10.1016/j.jvsv.2018.08.00230336908
  • Li W, Chuanlin Z, Shaoyu M, Yeh CH, Liqun C, Zeju Z. Catheter-directed thrombolysis for patients with acute lower extremity deep vein thrombosis: a meta-analysis. Rev Lat Am Enfermagem. 2018;26:e2990. doi:10.1590/1518-8345.2309.299029947719
  • Oklu R, Wicky S. Catheter-directed thrombolysis of deep venous thrombosis. Semin Thromb Hemost. 2013;39:446–451. doi:10.1055/s-0033-133414223483455
  • Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000;32:130–137. doi:10.1067/mva.2000.10566410876214
  • Hofmann LV, Kuo WT. Catheter-directed thrombolysis for acute DVT. Lancet. 2012;379:3–4. doi:10.1016/S0140-6736(11)61875-822172245
  • Delis KT, Bjarnason H, Wennberg PW, Rooke TW, Gloviczki P. Successful iliac vein and inferior vena cava stenting ameliorates venous claudication and improves venous outflow, calf muscle pump function, and clinical status in post-thrombotic syndrome. Ann Surg. 2007;245:130–139. doi:10.1097/01.sla.0000245550.36159.9317197976
  • Neglen P, Thrasher TL, Raju S. Venous outflow obstruction: an underestimated contributor to chronic venous disease. J Vasc Surg. 2003;38:879–885. doi:10.1016/S0741-5214(03)01020-614603188
  • Venous news by Mark Garcia. Available from: https://venousnews.com/access-pts-study-brings-hope-for-post-thrombotic-syndrome-patients/www.ClinicalTrials.govidentifier:NCT02159521. Accessd March 26, 2019.
  • Available from: https://evtoday.com/device-guide/europe/chart.asp?id=155. Accessed 123, 2019.
  • Available from: https://veindirectory.org/magazine/article/industry-updates/update-on-venous-stents. Accessed 123, 2019.
  • Lichtenberg M, de Graaf R, Stahlhoff WF, Özkapi A, Simon M, Breuckmann F. Patency rates, safety and clinical results of the sinus-Obliquus venous stent in the treatment of chronic ilio-femoral venous outflow obstruction - data from the Arnsberg venous registry. Vasa. 2018;1–6. doi:10.1024/0301-1526/a000772.
  • Milinis K, Thapar A, Shalhoub J, Davies AH. Antithrombotic therapy following venous stenting: international delphi consensus. Eur J Vasc Endovasc Surg. 2018;55(4):537–544. doi:10.1016/j.ejvs.2018.01.00729449145
  • Endo M, Jahangiri Y, Horikawa M, et al. Antiplatelet Therapy is Associated with Stent Patency After Iliocaval Venous Stenting. Cardiovasc Intervent Radiol. 2018;41(11):1691–1698. doi:10.1007/s00270-018-2062-530120531
  • Padrnos LJ, Garcia D. May-Thurner syndrome and thrombosis: A systematic review of antithrombotic use after endovascular stent placement. Res Pract Thromb Haemost. 2018;3(1):70–78. eCollection 2019 Jan. doi:10.1002/rth2.12156.30656278
  • Stuck AK, Reich T, Engelberger RP, Sebastian T, Kucher N. Endovascular treatment of post-thrombotic and non thrombotic iliofemoral venous outflow obstructions with self-expanding nitinol stents. Vasa. 2018;47(4):319–325. doi:10.1024/0301-1526/a00069729512422
  • Dabir D, Feisst A, Thomas D, et al. Physical properties of venous stents: an experimental comparison. Cardiovasc Intervent Radiol. 2018;41:942–950.29492633